Charles R. Nosal

Also affiliated with Johns Hopkins Medicine, Interface (United States), Therapeutics Clinical Research, Io Therapeutics (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Trihydroxybenzaldoximes are Redox Cycling Inhibitors of ThDP-Dependent DXP Synthase”.

Trihydroxybenzaldoximes are Redox Cycling Inhibitors of ThDP-Dependent DXP Synthase

ACS Chemical Biology(2025)10.1021/acschembio.5c00025

N/A

0DataRank · unranked

2 citations

Ananya Majumdar, Netzahualcóyotl Arroyo‐Currás, Caren L. Freel Meyers, Charles R. Nosal

3-Hydroxy-Beta-Lactam Inhibitors of Dihydrofolate Synthetase

ACS Bio & Med Chem Au(2025)10.1021/acsbiomedchemau.5c00036

N/A

0DataRank · unranked

0 citations

Luting Fang, Charles R. Nosal, Timothy A. Wencewicz, Brett Virgin-Downey